Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles (Q36471831)

14 August 2017

1 reference

title

Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles (English)

1 reference

14 August 2017

0 references

Sebastien Viatte

1

1 reference

14 August 2017

Pedro M Alves

series ordinal

2

1 reference

14 August 2017

Pedro Romero

series ordinal

3

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Immunology & Cell Biology

14 August 2017

published in

1 reference

14 August 2017

volume

84

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

318-330

1 reference

In vitro Cytotoxic Activity of Thymus Cells sensitized to Alloantigens

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Structure of the human class I histocompatibility antigen, HLA-A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Structure, expression and divergence of T-cell receptor β-chain variable regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Specificity and degeneracy of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Immunotherapy: bewitched, bothered, and bewildered no more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Antigen-specific immunotherapy and cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of tumor antigens and T-cell epitopes, and its clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of T cell epitopes by the use of rapidly generated mRNA fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Quantitating protein synthesis, degradation, and endogenous antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Serological analysis of human tumor antigens: molecular definition and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Improved approach to identify cancer-associated autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Serial analysis of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of human tumor antigens and its implications for diagnosis and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Gene expression profiling: methodological challenges, results, and prospects for addiction research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Statistical analysis of MPSS measurements: application to the study of LPS-activated macrophage gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The MMA1 gene family of cancer-testis antigens has multiple alternative splice variants: characterization of their expression profile, the genomic organization, and transcript properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification and characterization of KAT, a novel gene preferentially expressed in several human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of alternatively spliced mRNA variants related to cancers by genome-wide ESTs alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

trome, trEST and trGEN: databases of predicted protein sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Computational methods for prediction of T-cell epitopes--a framework for modelling, testing, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Antigen processing is predictable: From genes to T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Empty MHC class I molecules come out in the cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

HLA class I transgenic mice: development, utilisation and improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

MHC class-I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

CD8+ T cell tolerance and cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Recognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Regulation of T cell function by NK cell receptors for classical MHC class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Specificity of the proteasome and the TAP transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Link between organ-specific antigen processing by 20S proteasomes and CD8(+) T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Immune recognition of a human renal cancer antigen through post-translational protein splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

An antigenic peptide produced by peptide splicing in the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Identification of New Splice Variants and Differential Expression of the Human Kallikrein 10 Gene, a Candidate Cancer Biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

Restriction by H-2 gene complex of transfer of cell-mediated immunity to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01447.X

10.1111/J.1440-1711.2006.01447.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference